"Chemotaxis, Leukocyte" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The movement of leukocytes in response to a chemical concentration gradient or to products formed in an immunologic reaction.
| Descriptor ID |
D002634
|
| MeSH Number(s) |
G04.198.424.233
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Chemotaxis, Leukocyte".
Below are MeSH descriptors whose meaning is more specific than "Chemotaxis, Leukocyte".
This graph shows the total number of publications written about "Chemotaxis, Leukocyte" by people in this website by year, and whether "Chemotaxis, Leukocyte" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 0 | 2 | 2 |
| 2003 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 3 | 10 | 13 |
| 2018 | 2 | 4 | 6 |
| 2019 | 1 | 4 | 5 |
| 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Chemotaxis, Leukocyte" by people in Profiles.
-
Complement Decay-Accelerating Factor is a modulator of influenza A virus lung immunopathology. PLoS Pathog. 2021 07; 17(7):e1009381.
-
A mechanism for matrikine regulation in acute inflammatory lung injury. JCI Insight. 2021 04 08; 6(7).
-
Cross-Talk Between Key Players in Patients with COVID-19 and Ischemic Stroke: A Review on Neurobiological Insight of the Pandemic. Mol Neurobiol. 2020 Dec; 57(12):4921-4928.
-
Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nat Commun. 2020 07 08; 11(1):3410.
-
Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS). Med Hypotheses. 2020 08; 141:109774.
-
Dapsone and doxycycline could be potential treatment modalities for COVID-19. Med Hypotheses. 2020 07; 140:109768.
-
[Loss of human ICOSLG results in combined immunodeficiency]. Med Sci (Paris). 2019 Aug-Sep; 35(8-9):625-628.
-
The Atypical Receptor CCRL2 Is Essential for Lung Cancer Immune Surveillance. Cancer Immunol Res. 2019 Nov; 7(11):1775-1788.
-
Effects of Obesity on Pulmonary Inflammation and Remodeling in Experimental Moderate Acute Lung Injury. Front Immunol. 2019; 10:1215.
-
Immune cell trafficking and retention in inflammatory bowel disease: mechanistic insights and therapeutic advances. Gut. 2019 09; 68(9):1688-1700.